Key takeaway
In an umbrella review of 46 records, telemedicine was linked to clinically relevant reductions in HbA1c (at least 0.5%) in people with diabetes, with larger drops in recently diagnosed patients and those starting above 8%. It showed no significant, meaningful effect on blood pressure, and the evidence was low to very low quality.
Study design
Overview of reviews
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Telemedicine is said to improve chronic care and self-management, but guidelines for diabetes, hypertension and dyslipidemia give no evidence-based advice on which components work for which patients. The authors set out to collect, synthesize and appraise the evidence on telemedicine's clinical effects.
Who and how
Umbrella review of systematic reviews and meta-analyses of randomized controlled trials, searching PubMed, EMBASE and the Cochrane Library. Two authors independently screened studies, extracted data and assessed quality. Of 3564 references, 46 records were included. Results were organized by intervention components and patient characteristics using predefined thresholds of clinical relevance, and overall certainty was graded with GRADE.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1In patients with diabetes, telemedicine produced significant and clinically relevant reductions in glycated hemoglobin (HbA1c) of at least 0.5% (a reduction of 0.5 percentage points or more).
- 2Reductions were larger in recently diagnosed patients and those with baseline HbA1c above 8%.
- 3Telemedicine had no significant and clinically meaningful effect on blood pressure.
- 4Only reviews reporting lipid outcomes in people with diabetes were found, so dyslipidemia could not be assessed alone. GRADE rated the overall evidence as low to very low quality.
Limits & uncertainty
- 1GRADE certainty was low to very low, so the true effects may differ substantially from these estimates.
- 2Telemedicine covers many different tools, so the average result hides large differences between interventions, and subgroup findings rest on fewer reviews.
- 3Most included reviews were published after 2015 and overlap in their underlying trials is possible; the abstract does not report how it was handled. This reading is based on the abstract only.
What to take from it
For people with diabetes, remote monitoring and coaching programs may help lower HbA1c, especially soon after diagnosis or when levels are high, but the evidence is weak. For blood pressure the pooled evidence did not show a clear gain. Whether to use telemedicine for a condition is a decision for your care team.
Reading your own data
Remote programs often rely on data you already record, such as CGM or glucose meter values, home blood pressure readings and weight. Share a consistent record from the same device and conditions, and focus on multi-week trends.
How to read this evidence
Reviews may reuse the same trials. Review counts are not independent replications; study quality, overlap and outcome-specific certainty matter.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Telemedicine is defined by three characteristics: (1) using information and communication technologies, (2) covering a geographical distance, and (3) involving professionals who deliver care directly to a patient or a group of patients. It is said to improve chronic care management and self-management in patients with chronic diseases. However, currently available guidelines for the care of patients with diabetes, hypertension, or dyslipidemia do not include evidence-based guidance on which components of telemedicine are most effective for which patient populations.
Objective
The primary aim of this study was to identify, synthesize, and critically appraise evidence on the effectiveness of telemedicine solutions and their components on clinical outcomes in patients with diabetes, hypertension, or dyslipidemia.
Methods
We conducted an umbrella review of high-level evidence, including systematic reviews and meta-analyses of randomized controlled trials. On the basis of predefined eligibility criteria, extensive automated and manual searches of the databases PubMed, EMBASE, and Cochrane Library were conducted. Two authors independently screened the studies, extracted data, and carried out the quality assessments. Extracted data were presented according to intervention components and patient characteristics using defined thresholds of clinical relevance. Overall certainty of outcomes was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool.
Results
Overall, 3564 references were identified, of which 46 records were included after applying eligibility criteria. The majority of included studies were published after 2015. Significant and clinically relevant reduction rates for glycated hemoglobin (HbA_(1c); ≤-0.5%) were found in patients with diabetes. Higher reduction rates were found for recently diagnosed patients and those with higher baseline HbA_(1c) (>8%). Telemedicine was not found to have a significant and clinically meaningful impact on blood pressure. Only reviews or meta-analyses reporting lipid outcomes in patients with diabetes were found. GRADE assessment revealed that the overall quality of the evidence was low to very low.
Conclusions
The results of this umbrella review indicate that telemedicine has the potential to improve clinical outcomes in patients with diabetes. Although subgroup-specific effectiveness rates favoring certain intervention and population characteristics were found, the low GRADE ratings indicate that evidence can be considered as limited. Future updates of clinical care and practice guidelines should carefully assess the methodological quality of studies and the overall certainty of subgroup-specific outcomes before recommending telemedicine interventions for certain patient populations.
Sources & attribution
Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses.
Timpel P, Oswald S, Schwarz PEH, Harst L.
Journal of medical Internet research · 2020-03-18
DOI: 10.2196/16791 ↗PubMed · 32186516 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

